scholarly article | Q13442814 |
P356 | DOI | 10.1002/PROT.340190203 |
P698 | PubMed publication ID | 8090713 |
P2093 | author name string | A M Smallwood | |
D D Carlton | |||
E R Cook | |||
J C Spurlino | |||
J Falvo | |||
J S Johnson | |||
K J Vavra | |||
R C Wahl | |||
T A Pulvino | |||
T M Banks | |||
P2860 | cites work | The collagenase gene family in humans consists of at least four members | Q24292979 |
The Protein Data Bank: a computer-based archival file for macromolecular structures | Q27860989 | ||
Comparison of human stromelysin and collagenase by cloning and sequence analysis | Q42128842 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human fibroblast | Q101404861 |
P304 | page(s) | 98-109 | |
P577 | publication date | 1994-06-01 | |
P1433 | published in | Proteins | Q7251514 |
P1476 | title | 1.56 A structure of mature truncated human fibroblast collagenase | |
P478 | volume | 19 |
Q27741275 | 1.8‐Å Crystal Structure of the Catalytic Domain of Human Neutrophil Collagenase (Matrix Metalloproteinase‐8) Complexed with a Peptidomimetic Hydroxamate Primed‐Side Inhibitor with a Distinct Selectivity Profile |
Q42846595 | Analysis of zinc binding sites in protein crystal structures |
Q73178275 | Assignments and structure determination of the catalytic domain of human fibroblast collagenase using 3D double and triple resonance NMR spectroscopy |
Q73799023 | Assignments, secondary structure and dynamics of the inhibitor-free catalytic fragment of human fibroblast collagenase |
Q30500311 | Binary image representation of a ligand binding site: its application to efficient sampling of a conformational ensemble |
Q74155007 | Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy |
Q30358846 | Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion. |
Q54569111 | Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin |
Q41481774 | Collagenase: a key enzyme in collagen turnover |
Q57012706 | Comparing protein structures: A Gaussian-based approach to the three-dimensional structural similarity of proteins |
Q36809108 | Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography |
Q71984914 | Cooperative binding of Ca2+ to human interstitial collagenase assessed by circular dichroism, fluorescence, and catalytic activity |
Q28212260 | Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors |
Q73837352 | Docking studies of matrix metalloproteinase inhibitors: zinc parameter optimization to improve the binding free energy prediction |
Q73150867 | Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites |
Q47936331 | Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency. An explanation of inhibitor selectivity using homology modeling and chimeric proteins |
Q44321337 | Efficient conformational sampling of local side-chain flexibility |
Q27748874 | High-Resolution Solution Structure of the Inhibitor-Free Catalytic Fragment of Human Fibroblast Collagenase Determined by Multidimensional NMR |
Q28235879 | Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase |
Q28143236 | Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases |
Q54120593 | Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases |
Q28139348 | Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity |
Q40396352 | Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors |
Q92879530 | Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation |
Q42139331 | Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies |
Q51097575 | Mapping Lipid Bilayer Recognition Sites of Metalloproteinases and Other Prospective Peripheral Membrane Proteins |
Q47965876 | Matrix Metalloproteinase Inhibitors in Arthritis |
Q77455726 | Matrix metalloproteases: variations on a theme |
Q34850104 | Matrix metalloproteinases and collagen catabolism |
Q74105851 | Membrane Type-1 Matrix Metalloprotease and Stromelysin-3 Cleave More Efficiently Synthetic Substrates Containing Unusual Amino Acids in Their P1′ Positions |
Q41829912 | Methanethiol Binding Strengths and Deprotonation Energies in Zn(II)-Imidazole Complexes from M05-2X and MP2 Theories: Coordination Number and Geometry Influences Relevant to Zinc Enzymes |
Q44115744 | Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics |
Q38978663 | New biochemical insight of conserved water molecules at catalytic and structural Zn2+ ions in human matrix metalloproteinase-I: a study by MD-simulation. |
Q74166502 | Non-Peptidic Cysteine Derivatives as Inhibitors of Matrix Metalloproteinases |
Q27733457 | Novel zinc-binding centre in thermoacidophilic archaeal ferredoxins |
Q33356719 | Proteomic protease specificity profiling of clostridial collagenases reveals their intrinsic nature as dedicated degraders of collagen |
Q43760509 | Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors |
Q52260139 | QXP: powerful, rapid computer algorithms for structure-based drug design |
Q73419418 | Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases |
Q42846171 | Solution structures of stromelysin complexed to thiadiazole inhibitors |
Q42041891 | Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme |
Q28190760 | Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases |
Q35187217 | Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases |
Q42846145 | Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity. |
Q28144131 | Structural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexes |
Q40428339 | Structural features of a superfamily of zinc-endopeptidases: the metzincins |
Q27670630 | Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1 |
Q27732555 | Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller |
Q32056848 | Structure of malonic acid‐based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data |
Q73354919 | Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors |
Q77471936 | The Expression, Refolding, and Purification of the Catalytic Domain of Human Collagenase-3 (MMP-13) |
Q34108082 | The conformations of polypeptide chains where the main-chain parts of successive residues are enantiomeric. Their occurrence in cation and anion-binding regions of proteins 1 1 Edited by J. Thornton |
Q28207951 | The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling |
Q24675153 | The metzincins — Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc‐peptidases |
Q33692898 | The next generation of MMP inhibitors. Design and synthesis |
Q27620208 | The second type II module from human matrix metalloproteinase 2: structure, function and dynamics |
Q35000728 | Triple-helical peptide analysis of collagenolytic protease activity |
Q41902554 | Use of a novel microtitration protocol to obtain diffraction-quality crystals of 4-hydroxy-2-oxoglutarate aldolase from Bos taurus |
Q71346288 | X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily |
Search more.